- Home
- TLSA vs CNTY Comparison
TLSA vs CNTY Comparison
Compare TLSA & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSA | CNTY |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.1M | 36.0M |
| IPO Year | 2017 | 1996 |
Fundamental Metrics
Financial Performance| Metric | TLSA | CNTY |
|---|---|---|
| Price | $0.89 | $1.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 520.5K | 37.5K |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.31 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $430,529,000.00 |
| Revenue This Year | N/A | $7.17 |
| Revenue Next Year | N/A | $3.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.82 |
| 52 Week Low | $0.76 | $1.11 |
| 52 Week High | $2.35 | $2.73 |
Technical Indicators
Market Signals| Indicator | TLSA | CNTY |
|---|---|---|
| Relative Strength Index (RSI) | 43.22 | 35.17 |
| Support Level | N/A | N/A |
| Resistance Level | $1.20 | $1.33 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 42.61 | 3.33 |
Price Performance
Historical ComparisonAbout TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has five reportable segments based on the geographical locations in which its casinos operate; US East, US Midwest, US West, Canada, and Poland.